Abstract
Fluorescent compounds are used as markers to diagnose oncological diseases, to study molecular processes typical for carcinogenesis, and to investigate metastasis formation and tumor regress under the influence of therapeutics. Different types of tomography, such as continuous wave (CW), frequency-domain (FD), and time-domain (TD) tomography, allow fluorescence imaging of tumors located deep in human or animal tissue. In this work, preliminary results of the frequency domain fluorescent diffuse tomography (FDT) method in application to DsRed2 protein as a fluorescent agent are presented. For the first step of our experiments, we utilized low-frequency amplitude modulation (1 kHz) of second harmonic of Nd: YAG (532 nm). The transilluminative configuration was used in the setup. The results of post mortem experiments with capsules containing DsRed2 inserted inside the esophagus of a 3-day-old hairless rat to simulate tumor are shown. An algorithm of processing fluorescent images based on calculating the zero of maximum curvature has been applied to detect fluorescent inclusion boundaries in the image. This work demonstrates the potential capability of the FDT method for imaging deep fluorescent tumors in human tissue or animal models of human cancer. Improvement of the setup can be accomplished by using high-frequency modulation (using a 110-MHz acoustooptical modulator).
Similar content being viewed by others
References
A. M. Sergeev, L. S. Dolin, and D. H. Reitze, Opt. Photonics News, No. 7, 328 (2001).
S. Fantini, E. L. Heffer, H. Siebold, and O. Schutz, Opt. Photonics News, No. 11, 24 (2003).
Ch. Yu, Ch. Mu, X. Intes, and B. Chance, Opt. Express 9, 212 (2001).
R. M. Hoffman, Lab. Animal 31, 34 (2002).
M. Yang, E. Baranov, J.-W. Wang, et al., PNAS 99, 3824 (2002).
M. Bouvet, J. Wang, S. R. Nardin, et al., Cancer Res. 62, 1534 (2002).
M. H. Katz, S. Takimoto, D. Spivack, et al., J. Surg. Res. 113, 151 (2003).
R. Weissleder and V. Ntziachristos, Nat. Med. 9, 123 (2003).
M. V. Matz, A. F. Fradkov, Y. A. Labas, et al., Nat. Biotechnol. 17, 969 (1999).
B. Rashidi, M. Yang, P. Jiang, et al., Clin. Exp. Metastasis 18, 57 (2000).
M. H. Katz, S. Takimoto, D. Spivack, et al., Clin. Exp. Metastasis 21, 7 (2004).
M. A. O’Leary, D. A. Boas, X. D. Li, et al., Opt. Lett. 21, 123 (1996).
A. B. Milstein, J. J. Stott, D. A. Boas, et al., J. Opt. Soc. Am. A 21, 1035 (2004).
V. Ntziachristos, J. Ripoll, L. V. Wang, and R. Wesslender, Nat. Biotechnol. 23, 313 (2005).
V. Ntziachristos, E. A. Schellenberger, J. Ripoll, et al., PNAS 101, 12294 (2004).
S. V. Patwardhan, S. R. Bloch, S. Achilefu, and J. P. Culver, Opt. Express 13, 2564 (2005).
G. Zacharakis, J. Ripoll, R. Weissleder, and V. Ntziachristos, IEEE Trans. Med. Imaging 24, 878 (2005).
I. V. Turchin, V. I. Plehanov, E. A. Sergeeva, et al., SPIE Proc. 5859-57, 227 (2005).
V. Lyubimov, Opt. Spectrosc. 88, 282 (2000).
G. Patterson, R. N. Day, and D. Piston, J. Cell Sci. 114, 837 (2001).
D. C. Van Essen, H. A. Drury, S. Joshi, and M. Miller, Proc. Natl. Acad. Sci. USA 95, 788 (1998).
Author information
Authors and Affiliations
Additional information
Original Text © Astro, Ltd., 2006.
Rights and permissions
About this article
Cite this article
Turchin, I.V., Plehanov, V.I., Orlova, A.G. et al. Fluorescence diffuse tomography of small animals with DsRed2 fluorescent protein. Laser Phys. 16, 741–746 (2006). https://doi.org/10.1134/S1054660X06050021
Received:
Issue Date:
DOI: https://doi.org/10.1134/S1054660X06050021